129 related articles for article (PubMed ID: 34424600)
1. LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway.
Xu F; Hua Q; Zhang A; Di Z; Wang Y; Zhao L; Yang H; Liu J; Huang G
Cancer Sci; 2021 Nov; 112(11):4501-4514. PubMed ID: 34424600
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
3. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
4. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway.
Liu SY; Zhao ZY; Qiao Z; Li SM; Zhang WN
Cell Transplant; 2021; 30():963689720986071. PubMed ID: 33461333
[TBL] [Abstract][Full Text] [Related]
7. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
[TBL] [Abstract][Full Text] [Related]
8. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
10. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA DDX11-AS1 promotes non-small cell lung cancer development via regulating PI3K/AKT signalling.
Feng X; Yang S; Zhou S; Deng S; Xie Y
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1622-1631. PubMed ID: 32298476
[TBL] [Abstract][Full Text] [Related]
13. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.
Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M
Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA MIAT/miR-139-5p/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer.
Zeng F; Yu N; Han Y; Ainiwaer J
J Biosci; 2020; 45():. PubMed ID: 32345777
[TBL] [Abstract][Full Text] [Related]
15. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):222-229. PubMed ID: 31957835
[TBL] [Abstract][Full Text] [Related]
16. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
[TBL] [Abstract][Full Text] [Related]
18. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
19. c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.
Zhang E; Li W; Yin D; De W; Zhu L; Sun S; Han L
Tumour Biol; 2016 Mar; 37(3):4007-15. PubMed ID: 26482621
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
